ClinicalTrials.gg
Not yet recruitingNCT07558005CISSUpdated Apr 30, 2026

Many Trauma-affected Youth Face Long Waits for Therapy, Worsening Stress, and Avoidance. CISS, a 90-minute Session Based on Stanford's Cue-Centered Therapy, Offers Coping Tools and Psychoeducation During This Gap. This Pilot Tests CISS's Feasibility, Acceptability, and Impact on 30-40 Adolescents.

An interventional study of Cue-Centered Therapy (CCT)-Informed Single Session Intervention (CISS) in Wellbeing, Mental Health and Psychological, sponsored by Stanford University. Not yet recruiting. Open to participants aged 13 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-30.

Primary conditionPsychological Well-Being(the registry's first term)UnverifiedIs this wrong?Psychological Well-Being is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Stanford University · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
13 Years to 18 Years
Sex
All
01

Study summary

Many young people who have experienced traumatic events such as sexual assault, domestic violence, serious accidents, or natural disasters face long waits before they can begin full trauma-focused therapy. During this waiting period, symptoms such as avoidance, anxiety, and distress may worsen, and many youth lose motivation or confidence to start treatment. The Cue-Centered Therapy (CCT)-Informed Single Session Intervention (CISS) was designed to bridge this gap by offering a one-time, 90-minute session that teaches coping and self-understanding skills while youth are still on the waiting list.

This study is a pilot feasibility trial conducted in partnership between Stanford University and the University of Auckland. The purpose of the study is to evaluate whether CISS is a practical, acceptable, and safe intervention for young people aged 13-18 who have been exposed to trauma and are currently waiting for or hesitant to begin full-length therapy within New Zealand Hapai Ora Clinics.

Youth participants will meet once with a trained Hapai Ora clinician who will deliver the 90-minute CISS session. The session combines psychoeducation about trauma cues with skill-building strategies to improve coping, confidence, and readiness to engage in future treatment. Participants will complete short questionnaires before and after the session, and again at 3- and 6-month follow-ups. Measures will assess coping self-efficacy, treatment readiness, posttraumatic stress symptoms, and whether participants eventually begin full-length therapy.

The study will recruit approximately 30-40 adolescents across Hapai Ora clinical sites in Auckland, New Zealand. All clinicians providing the intervention are qualified mental-health professionals trained in both CISS and child-safety protocols. Participation involves minimal risk-similar to discussing difficult topics in a supportive therapy session.

Findings from this pilot study will help researchers understand whether CISS can be feasibly and safely delivered within public mental-health services, and whether it shows promise in helping young people build coping skills, reduce avoidance, and increase readiness to start therapy. The results will guide future larger-scale trials and inform the development of single-session, early-intervention approaches for trauma-exposed youth worldwide.

Read the detailed description

Trauma-exposed youth often face months-long waits before beginning comprehensive trauma-focused therapy, leaving them without structured support during a critical period of need. During these waiting periods, symptoms such as avoidance, anxiety, and hyperarousal may worsen, and many young people lose motivation or confidence to begin care. Brief, single-session interventions (SSIs) have emerged as a promising approach to strengthen coping and treatment engagement among youth unable or unwilling to access longer-term therapy.

The Cue-Centered Therapy (CCT)-Informed Single Session Intervention (CISS) is a 90-minute, structured, one-on-one session derived from the evidence-based Cue-Centered Therapy model developed at Stanford University's Early Life Stress and Resilience Program. CISS distills key CCT components-psychoeducation about trauma cues, development of insight into avoidance patterns, and flexible coping skill practice-into a single, accessible format designed to serve as a "bridge-to-care" for youth awaiting therapy.

This pilot feasibility trial will evaluate whether CISS can be feasibly and safely delivered to adolescents (ages 13-18) who have been exposed to trauma and are currently on Hapai Ora waitlists in New Zealand. The study is a collaboration between Stanford University and the University of Auckland.

Primary objectives:

  • Assess the feasibility and acceptability of CISS delivery within routine Hapai Ora workflows.
  • Examine pre- to post-intervention changes in coping self-efficacy, treatment readiness, and posttraumatic stress symptoms (PTSD symptoms).
  • Explore treatment uptake and engagement in full-length trauma therapy following participation.

Approximately 30-40 adolescents will be recruited through collaborating Hapai Ora sites. After informed consent or assent, participants will complete baseline questionnaires, attend a single 90-minute CISS session with a trained clinician, and complete post-session, 3-month, and 6-month follow-up assessments. All measures are brief, self-reported, and non-invasive. Core instruments include:

  • Children's Revised Impact of Event Scale (CRIES-8): measuring posttraumatic stress symptom severity (primary PTSD outcome)
  • Motivation for Youth Treatment Scale - Readiness Subscale (MYTS-R): measuring treatment readiness

    -.Credibility and Expectancy Questionnaire - Youth, Trauma-Focused (CEQ-Y-TF): measuring perceived credibility and expectancy of benefit

  • General Help-Seeking Questionnaire (GHSQ): measuring coping self-efficacy and help-seeking intentions

The study uses a single-group, pre-post feasibility design. Sessions are delivered by licensed Hapai Oraclinicians (e.g., psychologists, psychiatrists, nurses, or social workers) trained in CISS through Stanford- and Auckland-led workshops. Fidelity is monitored through checklists and optional video review for supervision. Data will be stored securely on Stanford Medicine's Qualtrics and Box servers, with all identifiable information removed prior to analysis.

Risks are minimal and limited to temporary emotional discomfort when discussing past trauma. All clinicians follow standard crisis-management and child-safety procedures, and participants have access to ongoing clinical support through Hapai Ora. No invasive procedures or medications are involved.

The anticipated study duration is from December 2025 to November 2028. Primary data collection (including 6-month follow-ups) is expected to conclude by May 2028. Findings will inform the design of a larger randomized controlled trial and contribute to international efforts to improve early trauma intervention accessibility within youth mental-health systems.

02

Conditions studied

  • Wellbeing
  • Mental Health
  • Psychological
  • Stress
  • Trauma Exposure

Browse trials for

Keywords

  • Trauma Intervention
  • CISS
  • Cue Centered Therapy (CCT)
  • Single-Session Intervention
  • Chronic Trauma
  • Trauma
03

In context

Psychological Well-Being Unverified

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

This study's planned enrollment of 40 is below the median of 110 across 1,808 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.

Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.

Compared within Psychological Well-Being, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: 13 to 18 years old (adolescents).

Trauma Exposure: History of chronic or single-event trauma (e.g., interpersonal violence, serious accidents, natural disaster) as documented in Child and Adolescent Mental Health Services (CAMHS) intake records.

Service Status: Currently on a CAMHS waitlist for trauma-focused therapy, or self-referred but hesitant to begin multi-session treatment.

Capacity and Consent: Ability to provide informed assent (ages 13-15 with parental permission) or (ages 16-18).

Exclusion criteria

Exclusion Criteria:

Current Trauma Treatment: Actively engaged in any form of trauma-focused psychotherapy (e.g., TF-CBT, EMDR, CCT) at the time of enrollment.

Severe Cognitive Impairment: Intellectual disability or cognitive impairment (e.g., IQ \< 70) that precludes comprehension of psychoeducational material or completion of self-report questionnaires.

Acute Suicidality: Endorsement of imminent self-harm or suicide risk (e.g., PHQ-9 item 9 ≥ 2) during screening that necessitates immediate crisis management rather than study participation.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Other
    Cue-Centered Therapy (CCT)-Informed Single Session Intervention (CISS)

    Participants will receive a single 90-minute CISS session, a structured, therapist-led program based on Cue-Centered Therapy (CCT). The session combines psychoeducation about trauma cues, guided reflection on avoidance and stress reactions, and skills practice to strengthen coping and treatment readiness. Sessions are delivered individually by trained mental-health clinicians (psychologists, psychiatrists, nurses, or social workers) working in Child and Adolescent Mental Health Services (CAMHS). All clinicians complete CISS training and fidelity supervision before implementation.Each youth completes baseline questionnaires before the session, a brief post-session survey, and follow-up assessments at 3 and 6 months. No control group or randomization is used in this pilot feasibility design.

    Other: Cue-Centered Therapy (CCT)-Informed Single Session Intervention (CISS)

Interventions

  • OtherCue-Centered Therapy (CCT)-Informed Single Session Intervention (CISS)

    Cue-Centered Therapy (CCT)-Informed Single Session Intervention (CISS) Arm Description: Participants will receive a single 90-minute CISS session, a structured, therapist-led program based on Cue-Centered Therapy (CCT). The session combines psychoeducation about trauma cues, guided reflection on avoidance and stress reactions, and skills practice to strengthen coping and treatment readiness. Sessions are delivered individually by trained mental-health clinicians (psychologists, psychiatrists, nurses, or social workers) working in Hapai Ora clinics. All clinicians complete CISS training and fidelity supervision before implementation.Each youth completes baseline questionnaires before the session, a brief post-session survey, and follow-up assessments at 3 and 6 months. No control group or randomization is used in this pilot feasibility design.

    Also known as: Single Session Intervention

06

What researchers measure

Primary outcomes

  1. Feasibility of Implementing CISS within CAMHS Services

    Feasibility will be evaluated using quantitative indices, including recruitment rate. Recruitment feasibility will be defined as the proportion of eligible participants who consent and complete the CISS session. Implementation feasibility will be indicated by the proportion of clinicians completing training and achieving ≥85% fidelity on observed sessions. Data will be summarized descriptively to determine whether CISS can be integrated into routine Hapai Ora workflows.

    Time frame: From the study start in June 2026 for 12 weeks

  2. Feasibility of Implementing CISS within CAMHS Services

    Feasibility will be evaluated using quantitative indices, including session completion rate. Recruitment feasibility will be defined as the proportion of eligible participants who consent and complete the CISS session. Implementation feasibility will be indicated by the proportion of clinicians completing training and achieving ≥85% fidelity on observed sessions. Data will be summarized descriptively to determine whether CISS can be integrated into routine Hapai Ora workflows.

    Time frame: From the study start in June 2026 for 12 weeks

  3. Feasibility of Implementing CISS within CAMHS Services

    Feasibility will be evaluated using quantitative indices, including follow-up completion rate. Recruitment feasibility will be defined as the proportion of eligible participants who consent and complete the CISS session. Implementation feasibility will be indicated by the proportion of clinicians completing training and achieving ≥85% fidelity on observed sessions. Data will be summarized descriptively to determine whether CISS can be integrated into routine Hapai Ora workflows.

    Time frame: From the study start in June 2026 for 12 weeks

  4. Feasibility of Implementing CISS within CAMHS Services

    Feasibility will be evaluated using quantitative indices, including clinician fidelity scores. Recruitment feasibility will be defined as the proportion of eligible participants who consent and complete the CISS session. Implementation feasibility will be indicated by the proportion of clinicians completing training and achieving ≥85% fidelity on observed sessions. Data will be summarized descriptively to determine whether CISS can be integrated into routine Hapai Ora workflows.

    Time frame: From the study start in June 2026 for 12 weeks

  5. Acceptability of CISS to Youth Participants and Clinicians

    Acceptability will be assessed through post-session surveys completed by youth and clinicians. Youth will rate satisfaction using 5-point Likert scales (1 = Not at all, 5 = Extremely). Clinicians will complete a brief acceptability checklist evaluating ease of delivery, perceived fit with clinical practice, and satisfaction with supervision. Acceptability will be operationalized as ≥80% of youth and clinicians endorsing ratings of 4 or higher on satisfaction and helpfulness items.

    Time frame: Immediately post-session

  6. Acceptability of CISS to Youth Participants and Clinicians

    Acceptability will be assessed through post-session surveys completed by youth and clinicians. Youth will rate perceived helpfulness using 5-point Likert scales (1 = Not at all, 5 = Extremely). Clinicians will complete a brief acceptability checklist evaluating ease of delivery, perceived fit with clinical practice, and satisfaction with supervision. Acceptability will be operationalized as ≥80% of youth and clinicians endorsing ratings of 4 or higher on satisfaction and helpfulness items.

    Time frame: Immediately post-session

  7. Acceptability of CISS to Youth Participants and Clinicians

    Acceptability will be assessed through post-session surveys completed by youth and clinicians. Youth will rate the likelihood of recommending the session using 5-point Likert scales (1 = Not at all, 5 = Extremely). Clinicians will complete a brief acceptability checklist evaluating ease of delivery, perceived fit with clinical practice, and satisfaction with supervision. Acceptability will be operationalized as ≥80% of youth and clinicians endorsing ratings of 4 or higher on satisfaction and helpfulness items.

    Time frame: Immediately post-session

  8. Change in Treatment Readiness

    The Motivation for Youth Treatment Scale - Readiness Subscale (MYTS-R) measures adolescents' readiness and motivation to engage in therapy. The MYTS-R consists of 8 items rated on a 5-point Likert scale from 1 ("Strongly disagree") to 5 ("Strongly agree"). Higher scores indicate greater readiness to participate in therapy. Mean changes in MYTS-R scores will be analyzed from baseline (pre-session) to immediate post-session, 3-month, and 6-month follow-ups.

    Time frame: Baseline (pre-session), immediate post-session, 3 months, 6 months

  9. Change in Coping Self-Efficacy and Help-Seeking Intentions

    The General Help-Seeking Questionnaire (GHSQ) evaluates adolescents' perceived coping ability and likelihood of seeking help for emotional or mental-health problems. Items are rated on a 7-point scale (1 = extremely unlikely, 7 = extremely likely). Higher scores indicate stronger coping self-efficacy and help-seeking intentions. Mean changes from baseline to follow-up will assess improvement in self-efficacy and help-seeking behavior.

    Time frame: Baseline (pre-session), 3 months, 6 months

  10. Change in Perceived Credibility and Expectancy for Treatment

    The Credibility and Expectancy Questionnaire - Youth, Trauma-Focused (CEQ-Y-TF) measures youths' perceptions of the intervention's credibility and their expectations of benefit. Six items are rated on 9-point Likert scales, with higher scores reflecting greater perceived credibility and expectancy. Mean CEQ-Y-TF scores will be compared between baseline and immediate post-session to assess change in perceived treatment plausibility and anticipated effectiveness.

    Time frame: Baseline (pre-session), immediate post-session

Secondary outcomes

  1. Change in Posttraumatic Stress Symptoms

    The Children's Revised Impact of Event Scale - 8 item (CRIES-8) measures posttraumatic stress symptom severity (intrusion, avoidance, and arousal). Each item is rated on a 4-point scale (0 = Not at all, 5 = Often). Higher scores indicate greater symptom severity. Mean total CRIES-8 score changes will be evaluated from baseline to 3- and 6-month follow-ups as an exploratory clinical outcome.

    Time frame: Baseline (pre-session), 3 months, 6 months

  2. Mean Change in School Achievement

    Description: School achievement was assessed with the Wide Range Achievement Test-Revised Spelling and Math scale score. The spelling subscale was a phonetic test that assessed the degree to which students could encode sounds into written words. The math computation subscale measured students' ability to identify numbers, count, and solve written computational problems. The scores are summed across the subscales and scaled according to the standardized score. A higher score reflects a higher performance. Changes in scores will be assessed between all time points.

    Time frame: Three time points: Baseline, 12 months, 24 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for May 2028, 23 months later.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 23 months is above that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2025
First posted
Apr 30, 2026
StartEst.
Jun 1, 2026
Primary completionEst.
May 31, 2028
CompletionEst.
Nov 30, 2028
Last update
Apr 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07558005
Collaborators
University of Auckland, New Zealand, Health New Zealand
Responsible party
Victor Carrion (The John A. Turner, M.D. Endowed Chair of Child and Adolescent Psychiatry Professor and Vice-Chair, Department of Psychiatry and Behavioral Sciences Director, Early Life Stress and Resilience Program, Stanford University) — Principal investigator
First posted
Apr 30, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
May 31, 2028 (estimated)
Completion
Nov 30, 2028 (estimated)
Last update
Apr 30, 2026

Study contacts

Melody Kim, PHD (G4)
Contact
melkim@stanford.edu
0211615296
Elizabeth Santana, BA, Political Science
Contact
eliz5@stanford.edu
6507213582
Victor Carrion, MD
principal investigator · Stanford University
Melody Kim, PHD (G4)
principal investigator · University of Aukland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion